
Peekcell offers a non-invasive urine-based cancer screening for women, powered by AI to analyze biomarkers. The system uses a proprietary AI algorithm to interpret biomarker signals from urine. It serves healthcare providers and clinics as a B2B diagnostic platform, leveraging cloud analytics and secure data handling. The solution aims to enable scalable screening workflows and improve early detection at a population level.

Peekcell offers a non-invasive urine-based cancer screening for women, powered by AI to analyze biomarkers. The system uses a proprietary AI algorithm to interpret biomarker signals from urine. It serves healthcare providers and clinics as a B2B diagnostic platform, leveraging cloud analytics and secure data handling. The solution aims to enable scalable screening workflows and improve early detection at a population level.